<DOC>
	<DOCNO>NCT03016598</DOCNO>
	<brief_summary>This study investigate effect intranasal administration oxytocin , social neuropeptide , reduction stimulant use , enhance group cohesion therapeutic engagement , susceptibility stress-induced relapse Veterans stimulant use disorder .</brief_summary>
	<brief_title>Stimulant Oxytocin Study</brief_title>
	<detailed_description>High rate substance use disorder ( SUDs ) Veterans compare general population heavily influence psychosocial factor - difficulty reintegrate civilian life due avoidance vital support system - lead disproportionately elevate unmet addiction treatment need . Administering oxytocin , mammalian neuropeptide , intranasally healthy control facilitate stress-buffering property social support . Oxytocin may also independent role mitigate symptom SUDs . For example , animal model addiction , oxytocin administration directly reduce tolerance , withdrawal effect , self-administration , stress-induced reinstatement drug seek range addictive substance . Moreover , oxytocin play role modulate hypothalamic-pituitary-adrenal ( HPA ) axis , involve stress-induced SUD relapse . While result early translational work oxytocin SUDs human , include pilot work , promising , finding vary base social context . A integrated understanding oxytocin 's distinct effect behavior psychology 1 ) addiction , 2 ) sociality , 3 ) stress reactivity could key define oxytocin 's role SUD treatment . This particularly relevant Veterans SUDs , disadvantage due increase rate comorbid avoidant attachment - measurable personality variant define avoidance social intimacy overvalue independence - posttraumatic stress symptom prevent retention exist SUD treatment paradigm heighten vulnerability stress-induced substance use . This study uniquely combine psychopharmacological evidence-based psychosocial intervention target improve sociality , treatment engagement , stress responsivity enhance overall recovery among Veterans SUDs .</detailed_description>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . At least 18 year old 2 . One documented urine toxicology screen positive stimulant within past month 3 . Stimulant use disorder ( must primary substance use disorder exception nicotine ) 4 . Veteran 1 . DSMV criteria previous current schizophrenia , schizoaffective disorder , bipolar disorder ; severe neuropsychological disorder , premenstrual dysphoric disorder , current moderatesevere alcohol use disorder 2 . Suicidal homicidal ideation within past 90 day suicide attempt past 6 month 3 . Hemodialysis 4 . Sensitivity E216 , E218 , chlorbutanol hemihydrate ( preservative nasal spray ) 5 . Using hormone supplementation 6 . Using 5HT1a agonist/antagonist 7 . Positive urine pregnancy test woman childbearing age practice effective mean nonhormonal birth control 8 . Chronic nasal obstruction , discharge , bleed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>oxytocin</keyword>
	<keyword>substance-related disorder</keyword>
	<keyword>Motivational Interviewing</keyword>
	<keyword>Psychophysiology</keyword>
	<keyword>Psychotherapeutic process</keyword>
</DOC>